Back to Academy
Phase 11: Industry Headaches 路 Lesson 3All Levels

Beauty: ingredient data, INCI lists, and compliance across markets

Lesson 75 of 813 min read

Beauty's defining data headache is that its most important product data is regulated. Ingredient lists aren't marketing copy - they're legally mandated disclosures (INCI format in the EU under the Cosmetics Regulation), they change per formulation batch, customers genuinely read them (allergy sufferers, ingredient-conscious shoppers - a large and growing segment), and the claims built on them ("fragrance-free," "vegan," "non-comedogenic") each carry their own substantiation requirements that vary by market. Most beauty catalogs handle all this as a text blob pasted into the description. That's the headache; here's the structure.

INCI as structured data, not paragraph

The core move, pure Phase 2: the ingredient list becomes a structured field - ideally a list-type metafield of INCI names in declaration order (order is legally meaningful: descending concentration above 1%) - with the formulation version and effective date alongside it. What structure buys over the blob: searchability and filtering ("fragrance-free," "contains niacinamide" as real filters - for ingredient-conscious customers this is the shopping experience, and it runs on exactly the facet machinery from Phase 5); consistency at the brand level (one canonical INCI spelling per ingredient across the catalog - the closed-list doctrine; "Aqua/Water/Eau" chaos is beauty's version of the fourteen linens); change management (reformulations arrive as data updates with dates - Phase 10's versioning discipline, here with legal weight, because the shipped product and the displayed list must match per batch transition); and derivation - the claims layer computed from the ingredient layer where possible ("fragrance-free" as a check against the INCI list, not a vibe someone typed), which turns a compliance risk into a validation rule.

Claims and the per-market matrix

The claims vocabulary ("hypoallergenic," "clean," "dermatologically tested," "reef-safe") is where beauty marketing meets per-market regulation, and the two worst practices are winging it and hard-coding it per market. The structural answer from Phase 9: claims as structured attributes with substantiation notes, rendered per market through conditional rules, with the market-requirements matrix owned and reviewed (EU claims criteria, per-country enforcement flavors, and the labeling specifics - responsible-person details, PAO symbols, nanomaterial disclosure - each a data field plus a rendering rule, not per-market page copy). The discipline sounds heavy; in practice it's a one-time modeling exercise plus the annual requirements review, and it's dramatically lighter than the alternative - which is discovering per-market claim problems via a competitor's complaint or a platform delisting.

The discoverability dividend

Here's the reframe that makes beauty's compliance burden a competitive asset: the same structured ingredient and claims data that satisfies the regulation is precisely what modern discovery consumes. Ingredient-level queries dominate beauty search ("niacinamide serum without fragrance" - a fanout-shaped, constraint-laden query, Phase 6's home territory); AI assistants answering "is [product] safe for sensitive skin" extract from exactly these fields when they're extractable, and guess when they're blobs; and Google's product experiences increasingly surface ingredient facets directly. Brands that structured this data for compliance find themselves accidentally optimized for the most valuable queries in their category - while competitors' INCI paragraphs are invisible to every one of those surfaces. Compliance-grade data, discoverability-grade returns: one structure, both payouts. That's the pattern this phase keeps finding.